“Stiffness Has Different Meanings, I Think, to Everyone”: Examining Stiffness From the Perspective of People Living With Rheumatoid Arthritis

Arthritis Care and Research

Volumn 66, Issue 11, 2014, Pages 1662-1672

  Orbai, Ana Maria ^a   Smith, Katherine C ^a   Bartlett, Susan J ^a,b   De Leon, Elaine ^a   Bingham, Clifton O ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ADULT; ARTICLE; CONTROLLED STUDY; DIET; DISEASE EXACERBATION; FEAR; FEMALE; HEALTH STATUS; HEAT; HUMAN; IMMOBILITY; ISOLATION; MALE; PAIN; PHYSICAL ACTIVITY; RHEUMATOID ARTHRITIS; RIGIDITY; SEASON; SELF CARE; STRESS; SWELLING; WEATHER;

EID: 85007188871     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22374     Document Type: Article

References (32)

1. The Cooperative Clinics Committee of the American Rheumatism Association.A seven-day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965;8:302–34.
2. Hewlett S, Sanderson T, May J, Alten R, Bingham CO III, Cross M, et al. ‘I'm hurting, I want to kill myself.’ Rheumatoid arthritis flare is more than a high joint count: an international patient perspective on flare where medical help is sought. Rheumatology (Oxford) 2012;51:69–76.
3. Mallya RK, Mace BE. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheumatol Rehabil 1981;20:14–7.
4. Jacobsson LT, Knowler WC, Pillemer S, Hanson RL, Pettitt DJ, McCance DR, et al. A cross-sectional and longitudinal comparison of the Rome criteria for active rheumatoid arthritis (equivalent to the American College of Rheumatology 1958 criteria) and the American College of Rheumatology 1987 criteria for rheumatoid arthritis. Arthritis Rheum 1994;37:1479–86.
5. Bingham CO III, Alten R, Bartlett SJ, Bykerk VP, Brooks PM, Choy E, et al. Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop. J Rheumatol 2011;38:1751–8.
6. Bartlett SJ, Hewlett S, Bingham CO III, Woodworth TG, Alten R, Pohl C, et al. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis 2012;71:1855–60.
7. Wright V, Plunkett TG. Scientific assessment of the results of physical treatment: measurement of stiffness. Ann Phys Med 1966;8:280–91.
8. Backlund L, Tiselius P. Objective measurement of joint stiffness in rheumatoid arthritis. Acta Rheumatol Scand Suppl 1967;13:275–88.
9. Hicklin JA, Wighton RJ, Robinson FJ. Measurement of finger stiffness. Ann Phys Med 1968;9:234–42.
10. Tiselius P. Studies on joint temperature, joint stiffness and muscle weakness in rheumatoid arthritis: an experimental and clinical investigation. Acta Rheumatol Scand Suppl 1969;14 Suppl 14:75–86.
11. Helliwell PS, Howe A, Wright V. The measurement of stiffness in the rheumatoid hand. Eng Med 1987;16:203–7.
12. Helliwell PS, Howe A, Wright V. Lack of objective evidence of stiffness in rheumatoid arthritis. Ann Rheum Dis 1988;47:754–8.
13. Rhind VM.The validity and inter-relationship of subjective and objective measurements of stiffness in human joints [thesis].Durham (UK):Durham University; 1988.
14. Wright V. Measurement of outcome in rheumatic diseases. J R Soc Med 1985;78:985–94.
15. Hazes JM, Hayton R, Burt J, Silman AJ. Consistency of morning stiffness: an analysis of diary data. Br J Rheumatol 1994;33:562–5.
16. Tavares R, Wells GA, Bykerk VP, Guillemin F, Tugwell P, Bell MJ. Validation of a self-administered inflammatory arthritis detection tool for rheumatology triage. J Rheumatol 2013;40:417–24.
17. Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, et al. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis 2013;72:204–10.
18. Van der Helm-van Mil AH, Detert J, le Cessie S, Filer A, Bastian H, Burmester GR, et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum 2008;58:2241–7.
19. Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis 2010;69:1589–95.
20. Rhind VM, Unsworth A, Haslock I. Assessment of stiffness in rheumatology: the use of rating scales. Br J Rheumatol 1987;26:126–30.
21. Khan NA, Spencer HJ, Abda E, Aggarwal A, Alten R, Ancuta C, et al. Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken) 2012;64:206–14.
22. Methodology Committee of the Patient-Centered Outcomes Research I.Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA 2012;307:1636–40.
23. US Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims (2009). URL: www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
24. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10 Suppl 2:S125–37.
25. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity. Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report. Part 1: eliciting concepts for a new PRO instrument. Value Health 2011;14:967–77.
26. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity. Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report. Part 2: assessing respondent understanding. Value Health 2011;14:978–88.
27. US Food and Drug Administration. Prescription drug user fee act of 2012 (PDUFA-V) reauthorization performance goals and procedures fiscal years 2013 through 2017. 2012. URL: http://www.fda.gov/downloads/forindustry/userfees/prescriptiondruguserfee/ucm270412.pdf.
28. De Wit MP, Berlo SE, Aanerud GJ, Aletaha D, Bijlsma JW, Croucher L, et al. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis 2011;70:722–6.
29. Boers M, Kirwan JR, Wels G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745–53.
30. Pope C, Ziebland S, Mays N. Qualitative research in health care: analysing qualitative data. BMJ 2000;320:114–6.
31. ATLAS.ti: 7.0.91 ed.Berlin:Scientific Software Development GmbH; 2012.
32. Drane D, Berry G, Bieri D, McFarlane AC, Brooks P. The association between external weather conditions and pain and stiffness in women with rheumatoid arthritis. J Rheumatol 1997;24:1309–16.